Table 1.
Demographic characteristics of subjects.
| Non-CHD | CHD | P | |
|---|---|---|---|
| N | 42 | 67 | |
| Age (year) | 56.79 ± 14.978 | 61.48 ± 12.73 | 0.096 |
| Sex (M/F) | 19/23 | 39/28 | 0.190 |
| Duration (year) | 10.10 ± 8.09 | 11.44 ± 7.50 | 0.387 |
| BMI (kg/m2) | 25.00 ± 4.73 | 25.94 ± 4.72 | 0.314 |
| Lymphocyte (109/L) | 1.76 ± 0.48 | 2.03 ± 0.89 | 0.041* |
| TG (mmol/L) | 2.02 ± 1.91 | 2.05 ± 1.43 | 0.937 |
| LDL-L (mmol/L) | 2.59 ± 0.71 | 3.35 ± 0.92 | 0.000** |
| HDL-L (mmol/L) | 1.22 ± 0.28 | 1.14 ± 0.24 | 0.134 |
| T-Cho (mmol/L) | 4.69 ± 1.01 | 5.24 ± 1.16 | 0.010* |
| CD4+ (%) | 37.83 ± 8.30 | 38.42 ± 10.28 | 0.743 |
| CRP (mg/L) | 2.27 ± 2.34 | 5.61 ± 4.21 | 0.000** |
| ln (HOMA-IR) | 0.66 ± 0.81 | 1.39 ± 0.64 | 0.000** |
BMI: body mass index; non-CHD: patients with type 2 diabettes but without CHD; CHD: patients with type 2 diabetes and CHD; CRP: C-reactive protein; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; T-Cho: total cholesterol; TG: total triglycerides.
*Statistically significant at level of P < 0.05.
**Statistically significant at level of P < 0.01.